Retrospective Study
Copyright ©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. Aug 21, 2022; 28(31): 4376-4389
Published online Aug 21, 2022. doi: 10.3748/wjg.v28.i31.4376
Preoperative contrast-enhanced computed tomography-based radiomics model for overall survival prediction in hepatocellular carcinoma
Peng-Zhan Deng, Bi-Geng Zhao, Xian-Hui Huang, Ting-Feng Xu, Zi-Jun Chen, Qiu-Feng Wei, Xiao-Yi Liu, Yu-Qi Guo, Sheng-Guang Yuan, Wei-Jia Liao
Peng-Zhan Deng, Bi-Geng Zhao, Xian-Hui Huang, Ting-Feng Xu, Zi-Jun Chen, Qiu-Feng Wei, Xiao-Yi Liu, Yu-Qi Guo, Sheng-Guang Yuan, Wei-Jia Liao, Laboratory of Hepatobiliary and Pancreatic Surgery, Affiliated Hospital of Guilin Medical University, Guilin 541001, Guangxi Zhuang Autonomous Region, China
Author contributions: Deng PZ, Zhao BG and Huang XH contributed equally to this work; Liao WJ was the guarantor and designed the study; Deng PZ, Zhao BG, Xu TF, Chen ZJ, Wei QF, and Liu XY participated in the acquisition, analysis, and interpretation of the data; Deng PZ and Huang XH drafted the initial manuscript; Guo YQ, Yuan SG, and Liao WJ revised the article critically for important intellectual content.
Supported by the National Natural Science Foundation of China, No. 81372163; the Science and Technology Planning Project of Guilin, No. 20190218-1; the Openin Project of Key laboratory of High-Incidence-Tumor Prevention & Treatment (Guangxi Medical University), Ministry of Education, No. GKE-KF202101; the Program of Guangxi Zhuang Autonomous Region health and Family Planning Commission, No. Z20210706; and the Innovation and Entrepreneurship Project of University Students in Guangxi, No. 202110601002.
Institutional review board statement: The study was reviewed and approved by the research ethics committee of Affiliated Hospital of Guilin Medical University (Approval NO. 2021WJWZC14).
Informed consent statement: Informed consent was obtained from all patients.
Conflict-of-interest statement: There are no conflicts of interest to report.
Data sharing statement: No additional data are available.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Wei-Jia Liao, MD, Chief Doctor, Professor, Laboratory of Hepatobiliary and Pancreatic Surgery, Affiliated Hospital of Guilin Medical University, No. 15 Lequn Road, Xiufeng District, Guilin 541001, Guangxi Zhuang Autonomous Region, China. liaoweijia288@163.com
Received: April 20, 2022
Peer-review started: April 20, 2022
First decision: June 2, 2022
Revised: June 14, 2022
Accepted: July 20, 2022
Article in press: July 20, 2022
Published online: August 21, 2022
ARTICLE HIGHLIGHTS
Research background

Hepatocellular carcinoma (HCC) is the most common primary liver malignancy. The prognosis of HCC patients remains poor. Radiomics is an artificial intelligent-based method for obtaining prognostic and predictive information which may contribute to clinical outcomes improvement.

Research motivation

Currently, a few studies have analysed the largest cross-sectional area of HCC tumour. In this study, we have analysed the entire-tumour to build a more comprehensive prognostic prediction model with clinical characteristics. We aimed to develop a radiomics model for predicting the overall survival of HCC patients after hepatectomy.

Research objectives

In this study, we aimed to develop a radiomics model based on contrast-enhanced computed tomography (CECT) images for predicting the overall survival of HCC patients after radical hepatectomy.

Research methods

A total of 150 HCC patients were enrolled and randomly divided into a training cohort (n = 107) and a validation cohort (n = 43) at ratio 2.5:1. Radiomics features were extracted from the CECT images. In training cohort, the least absolute shrinkage and selection operator algorithm was applied for radiomics features selection and radiomics signature construction. Univariate and multivariate Cox regression analyses were used to develop the predictive model. The accuracy of the model was assessed with the concordance index, receiver operating characteristic curve and calibration curve. The clinical practicality was evaluated by decision curve analysis. The survival between the low- and high-risk subgroups was compared using Kaplan–Meier methodology.

Research results

In total, seven radiomics features were selected to construct the radiomics signature. Alpha-fetoprotein, neutrophil-to-lymphocyte ratio and radiomics signature were identified as independent risk predictors to build the predictive model. The C-indices of the model in the training and validation cohorts were 0.736 and 0.774, respectively. In receiver operating characteristic curve for predicting 1-, 3-, and 5-year overall survival, area under the curve (AUC) = 0.850, 0.791 and 0.823, respectively in training cohort; AUC = 0.905, 0.884 and 0.911, respectively in validation cohort. The calibration curve analysis indicated a good agreement between the model-prediction and actual survival. Decision curve analysis suggested that the predictive model had more benefit than traditional staging system models. In Kaplan–Meier survival analysis, patients in the low-risk group had longer overall survival and disease-free survival.

Research conclusions

The predictive model is a reliable tool for predicting the overall survival of HCC patients after radical hepatectomy.

Research perspectives

More precise and reliable tool to predict the prognosis of HCC patients is urgently needed. Radiomics is a new method for obtaining prognostic and predictive information. In this study, we aimed to develop a predictive model based on CECT images and clinical-pathologic characteristics to predict the overall survival of HCC patients.